the more we know, the more we wonder.
the more we know,
the more we wonder.
Search
Close this search box.

Share

Reading Time: 4 min

p53 is an incredible protein whose function is to stop the neoplastic transformation and tumor progression. It acts like a collector of stress inputs and coordinator of pathways that protect cellular homeostasis and genome stability.
The missense mutations in the TP53 gene are very dangerous because a mutant p53 protein lose its tumor suppressive activities. In this scenario cancer cells acquire advantages thanks to the mutant p53 and its pathway promote the invasion, metastasis and chemoresistance. 

It could be understood how p53 it’s important in the tumor growth in fact the alternated form of this protein,TP53, is the most frequently altered gene in human tumors.
The first outcome of TP53 mutations is the loss of some p53 functions, the cell loses its suppressive responses, like senescence and apoptosis.
These selective advantages come from retaining only the mutant form of the p53 protein, so the wild-type p53 is lost.

In this image the blue lines represent the stress inputs, the red ones are the adaptive mechanisms.
The mutp53 helps the survival response to oxidative stress, increase the proteosome activity in human cancer cell, inhibit the DDR, DNA-damage response in HUPKI (Humanize mutp53 knock-in mice), promote the angiogenesis in breast cancer.

Mutp53 accumulation in tumors is also related to nutrient availability; it’s also to highlight that a glucose restriction diet reduced mutp53 accumulation in mutp53 knock-in mice.
The post-translational modifications are triggered by cancer-related stress stimuli.
When the mutp53 is accumulated the mechanism of autophagy-mediated degradation is suspended by the acetylation of C-terminal lysine; the modifications also enhance mutp53 oncogenic activities that promote breast cancer cells proliferation and chemoresistance.
Another post-translational modification enhances the ability of mutp53 to neutralize p63 anti-metastatic activity.
 
The hallmark of cancer
Cancer reprograms cell metabolism and due to this action tumor continues its growth and proliferation.
The Warburg effect consist in adaptation of cancer cells by increased glucose uptake by aerobic glycolysis. This mechanism feeds tumor growth in hypoxic conditions and due to extracellular acidification the immune system surveillance is held back.
The glucose flow is sustained by mutp53 by membrane translocation of the glucose transporter GLUT1, this is a crucial point for the cancer cell because tumors need high glucose level in face of nutrient scarcity. 
 
 Mutp53 promotes:
  • Cancer cell survival under stress conditions by the inhibition of the apoptotic and autophagic mechanism. 
  • Chemoresistance by the repression of p73 pro-apoptotic transcriptional program.
  • Suppression autophagy in tumor cell, in fact inhibits AMPK kinase that under metabolic stress stimulates autophagy.
  • Inhibition of the anti-metastatic p63 target gene Sharp1.
An important point in cancer cells is that they have to create a mechanism that favor adaptation to protein stress. In fact in these cells the accumulation of misfolded proteins in physiological conditions can trigger apoptosis. The cell can adapt to a proteotoxic stress thanks to mutp53 that make cancer cells more resistant. Mutp53 interact with Heat shock protein 1 (HSP1) to help cancer cells to survive by stimulating adaptation, preventing apoptosis and cutting pro-apoptotic circuit.
 
What we have to understand is that every type of tumor grows in a specific microenvironment that is crucial for its progression. Mutp53 helps cancer cells to adapt to hostile conditions, the tumor has to be well vascularized so mutp53 promotes tumor neo-angiogenesis by upregulating Inhibitor of DNA-binding protein 4 (ID4), member of ID protein, that enhances the expression of pro-angiogenic cytokines, like interleukin 8 (IL8).
Cancer cells keep on secreting a large number of molecules that help tumor growth to survive, reshape the microenvironment to sustain metastatic dissemination.
Mutp53 also collaborate with other molecules to help the tumor aggressiveness and growth, like NF-κB. In this scenario it amplifies the inflammatory response by cytokine production and the cancer it’s protected to cytotoxic effects activating pro-survival pathways.
 
Experiment has shown that interference with mutp53 expression or activity by pharmacological treatments decreases cancer cell proliferation and even causes tumor regression in vivo. Unfortunately anticancer therapies are far away from clinical practice, the only molecule that has reached the phase l/ll studies is APR-246. Other treatments ways to discover could exploit tumor cells synthetic lethal interactions, these could be new therapies for tumor characterized by high TP53 mutation rate like ovarian cancer.
Anticancer treatments could directly or not hit mutp53 homeostatic circuit and every pathway that mutp53 can express could be knock out by pharmacological therapies.
Back to top
Sign up for email updates

Enter your email address

Oncology simplified with logic.

As a biology student deepening my scientific interests, I wanted to make them more understandable to people outside this field.

So I thought of opening OnkologiK.com, a site where scientific topics are explained as simply as possible on the basis of authoritative sources on the subject.

New Client Offer

25%OFF

Leave your details below and receive a discount coupon in your inbox